Paper12395331
Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.
Hassan MM and 7 others. Hepatology, 2002. Cited by 588 papers, by iCite.
Cite this record
ConductScience Library. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Papers, record 12395331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12395331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alcohol Drinking | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Diabetes Mellitus, Type 1 | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Hepatitis B | Major topic |
| Hepatitis C | Major topic |
| Liver Neoplasms | Major topic |
| Aged | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Multivariate Analysis | |
| Prevalence | |
| Risk Factors |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 12395312 | Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology. | https://conductscience.org/library/papers/12395312 |
Source PubMed
Cited by290
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 588 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42860761 | Missed Diagnosis in Alcohol-Related Hepatocellular Carcinoma: A Call for Alcohol Consumption and Liver Disease Early Detection. | Liver Int | 2026 | https://conductscience.org/library/papers/42860761 | PubMed |
| 42615769 | Prevention, surveillance, and early detection of hepatocellular carcinoma - a Brazilian multidisciplinary consensus. | Arq Bras Cir Dig | 2026 | https://conductscience.org/library/papers/42615769 | PubMed |
| 42569746 | The Regeneration Paradox in Liver Cancer: How Chronic Injury Transforms Healing into Carcinogenesis. | Liver Cancer | 2026 | https://conductscience.org/library/papers/42569746 | PubMed |
| 42168268 | Global changes in gene expression and splicing in alcoholic liver disease. | Sci Rep | 2026 | https://conductscience.org/library/papers/42168268 | PubMed |
| 41939890 | GPX2+ tumor cells recruit LGALS1+ B cells via CCL26-CCR3 axis to promote immunosuppression and tumor progression in hepatocellular carcinoma. | Front Immunol | 2026 | https://conductscience.org/library/papers/41939890 | PubMed |
| 41041545 | Global Changes in Gene Expression and Splicing in Alcoholic Liver Disease. | Res Sq | 2025 | https://conductscience.org/library/papers/41041545 | PubMed |
| 40944258 | Alcohol and Tea Consumption in Relation to Liver Cancer Risk by Diabetes Status: A Prospective Cohort Study of 0.5 Million Chinese Adults. | Nutrients | 2025 | https://conductscience.org/library/papers/40944258 | PubMed |
| 40783888 | Ubiquitous Environmental Exposures and Risk of Hepatocellular Carcinoma: A Narrative Review. | Dig Dis Sci | 2026 | https://conductscience.org/library/papers/40783888 | PubMed |
| 40721214 | Public health strategies for hepatocellular carcinoma: from risk factors to prevention and control. | J Liver Cancer | 2025 | https://conductscience.org/library/papers/40721214 | PubMed |
| 40655398 | The impact of diabetes and social, biologic and behavioral determinants of health on liver cancer risk. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40655398 | PubMed |
| 40141002 | Hepatitis B surface antigen: carcinogenesis mechanisms and clinical implications in hepatocellular carcinoma. | Exp Hematol Oncol | 2025 | https://conductscience.org/library/papers/40141002 | PubMed |
| 39867264 | Risk and Prognosis of Hepatocellular Carcinoma in Mexican Americans with Type 2 Diabetes Mellitus. | J Hepatocell Carcinoma | 2025 | https://conductscience.org/library/papers/39867264 | PubMed |
| 39524465 | Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma. | J Immunother Precis Oncol | 2024 | https://conductscience.org/library/papers/39524465 | PubMed |
| 39362712 | Alcohol and Hepatocellular Carcinoma. | Clin Liver Dis | 2024 | https://conductscience.org/library/papers/39362712 | PubMed |
| 39301314 | Casual effects of type 1 diabetes mellitus on site-specific digestive cancers: a Mendelian randomisation analysis. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/39301314 | PubMed |
| 39240221 | Hepatocellular Carcinoma Etiology Drives Survival Outcomes: A Population-Based Analysis. | Cancer Epidemiol Biomarkers Prev | 2024 | https://conductscience.org/library/papers/39240221 | PubMed |
| 39120631 | Hepatitis B virus infection and the risk of gynecologic cancers: a systematic review and meta-analysis. | Discov Oncol | 2024 | https://conductscience.org/library/papers/39120631 | PubMed |
| 38977823 | Investigating the causal association between obesity and risk of hepatocellular carcinoma and underlying mechanisms. | Sci Rep | 2024 | https://conductscience.org/library/papers/38977823 | PubMed |
| 38692395 | Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes. | Gastroenterology | 2024 | https://conductscience.org/library/papers/38692395 | PubMed |
| 38426692 | Immunological pathways in viral hepatitis-induced hepato-cellular carcinoma. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2024 | https://conductscience.org/library/papers/38426692 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12395331
GET https://conductscience.org/api/papers/v1/12395331/cited_by?page=2